FDA Warning Letter — Centrient Pharmaceuticals India Private Limited
The FDA took a Warning Letter action against Centrient Pharmaceuticals India Private Limited on December 7, 2022 (Nawashahr, India). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Centrient Pharmaceuticals India Private Limited
- Date
- December 7, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Nawashahr (India)